ARCHIVES

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Clinton Signs Bill Creating NIH Center On Minority Health.

December 1, 2000

American Radium Society Abstracts

July 23, 1976

Antigenics Begins Phase II Trial Of Oncophage for NHL.

March 31, 2000

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

Professional Societies: AACI Seeks To Define Role Of Cancer Centers In Washington Politics

October 16, 1998